πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 405 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8933059

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8927576

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895539

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8889627

Treatment of multiple sclerosis with combination of laquinimod and fingolimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Almirall, S.A. Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8852936

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy

Laurantis Pharma Oy Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846649

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846648

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8841302

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8835405

Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitam

China Medical University Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809268

Combination therapy to combat helminth resistance

The Regents of the University of California Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8790652

Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules

VACCINEX, INC. Β· Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8778391

Flurbiprofen and muscle relaxant combinations

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728458

Combination anti-HIV vectors, targeting vectors, and methods of use

The Regents of the University of California Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8709417

Combination immunotherapy for the treatment of cancer

BOARD OF REGENTS Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691778

Flurbiprofen and muscle relaxant gel combinations thereof

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673964

Use of drug combinations for treating insulin resistance

DiaMedica Inc. Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663602

Method for high-throughput screening of compounds and combinations of compounds for discov

The Regents of the University of California Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658627

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637026

Anti-C35 antibody combination therapies and methods

VACCINEX, INC. Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637074

Methods for co-encapsulation of combination drugs and co-encapsulated combination drug pro

Aphios Corporation Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633178

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

E-Therapeutics PLC Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted